West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
Malaria is a major threat to public health and economic development of Africa.
The objectives of malaria control can never be achieved without strong involvement of those scientists who are directly affected by this terrible disease in their everyday life.
Until recently, the involvement of African scientists in international efforts to control malaria has been minimal. The European and developing Countries Clinical Trials Partnership (EDTCP) is an important initiative to strengthen the partnership between Africa and Europe through the development of vaccines and medicines clinical trials. The overall objective of this project is the development of a sub-region consisting of Burkina Faso, Guinea and Mali that is equipped with clinical trial sites and laboratories, qualified research teams and a study population well described prepared to undertake Phases I-IV trials for the development of new drugs against malaria.
- Developing antimalarial drugs
- Training of staff
- Networking through partnerships
- Developing research labs and field sites
Members of the Network
- Malaria Research and Training Center (MRTC), Université de Bamako, Bamako, Mali
- Centre National de Recherche et de Formation sur le Paludisme (CNRFP), Ouagadougou, Burkina Faso
- Institut de Recherche en Science de la Santé (IRSS), Bobo Dioulasso, Burkina Faso
- Centre National de formation et de Recherche en Santé Rurale (CNFRSR), Mafèrinyah, Guinea
- MRC Gambia, Gambie
- Unite de Recherche sur la Malaria, Université Claude Bernard, Lyon, France
- The Malaria Research Unit at the Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden
- London School of Hygiene & Tropical Medicine, London, United Kingdom
- Molecular-epidemiology of Malaria Group, University of Heidelberg School of Medicine, Heidelberg, Germany